AI Terminal
Fresenius Medical Care AG & Co. KGaA
Transaction in Own Shares • Mar 23, 2020
165_rns_2020-03-23_75c337e5-0467-4b38-81cc-06c5d7cf5c69.html
Transaction in Own Shares
Open in ViewerOpens in native device viewer
News Details
Other Capital Market Information | 23 March 2020 17:56
Fresenius Medical Care AG & Co. KGaA: Release of a capital market information
Fresenius Medical Care AG & Co. KGaA / Share buy-back
23.03.2020 / 17:56
Dissemination of a Post-admission Duties announcement transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Share buy-back – 40 th Interim Report
In the period from March 16, 2020 until and including March 20, 2020, a total of 449,021 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA (‘Fresenius Medical Care’) announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.
The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange and via selected multilateral trading facilities (MTF):
XETRA
Aggregated volume in Weighted average share number of shares price in EUR
| Day of repurchase | Aggregated volume in number of shares | Weighted average share price in EUR |
| 16.03.2020 | 344,779 | 56.40471 |
| 17.03.2020 | 9,953 | 59.2980 |
| 18.03.2020 | 9,187 | 58.8520 |
| 19.03.2020 | 3,000 | 58.3104 |
| 20.03.2020 | 990 | 57.3667 |
Chi-X Europe
| Day of repurchase | Aggregated volume in number of sharesAggregated volume in number of shares Aggregated volume in number of shares | Weighted average share price in EUR |
| 16.03.2020 | 57,482 | 56.57144 |
| 17.03.2020 | – | – |
| 18.03.2020 | – | – |
| 19.03.2020 | – | – |
| 20.03.2020 | – | – |
BATS Europe
| Day of repurchase | Aggregated volume in number of shares | Weighted average share price in EUR |
| 16.03.2020 | 9,652 | 56.4773 |
| 17.03.2020 | – | – |
| 18.03.2020 | – | – |
| 19.03.2020 | – | – |
| 20.03.2020 | – | – |
Turquoise
| Day of repurchase | Aggregated volume in number of shares | Weighted average share price in EUR |
| 16.03.2020 | 13,978 | 56.3285 |
| 17.03.2020 | – | – |
| 18.03.2020 | – | – |
| 19.03.2020 | – | – |
| 20.03.2020 | – | – |
The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including March 20, 2020 therefore amounts to 5,903,049 shares.
Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care’s website at www.freseniusmedicalcare.com under section Investors.
Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board
Bad Homburg v.d.H., March 23, 2020
23.03.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
| Language: | English |
| Company: | Fresenius Medical Care AG & Co. KGaA |
| Else-Kröner-Straße 1 | |
| 61352 Bad Homburg | |
| Germany | |
| Internet: | www.freseniusmedicalcare.com |
| End of News | DGAP News Service |